info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Research ArticleOpen Access

Role of FDG PET-CT in Distinction of Benign Thrombus and Tumor Thrombus in Oncological Patients

Volume 2 - Issue 4

Pelin Ozcan Kara1, Emel Yaman Sezer2, Zehra Pinar Koc1, Eda Bengi Yilmaz3 and Elvan Caglar Citak4

  • Author Information Open or Close
    • 1Department of Nuclear Medicine, Mersin University, Turkey
    • 2Department of Oncology, Mersin University, Turkey
    • 3Department of Radiation Oncology, Mersin University, Turkey
    • 4Department of Pediatric Oncology Mersin University, Turkey

    *Corresponding author: Pelin Ozcan Kara, Mersin University Hospital, Nuclear Medicine Dpt. 33343 Mersin/Turkey

Received: February 17, 2018;   Published: February 22, 2018

DOI: 10.26717/BJSTR.2018.02.000789

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Aim: Accurate diagnosis of tumor thrombus and distinguishing benign thrombus from tumor thrombus avoid unnecessary anticoagulant treatment of oncological patients and it is important for patient management. In this retrospective study, we aimed to demonstrate the role of FDG-PET/CT imaging for distinction of benign thrombus from tumor thrombus.

Materials and Methods:FDG-PET/CT imaging performed for staging, restaging and treatment response in oncological patients with thrombus were evaluated for accurate diagnosis of tumor thrombus and distinguishing benign thrombus from tumor thrombus by the examination of maximum standard uptake value (SUVmax). PET-CT imaging were evaluated both with visual assessment and increased metabolic activity. PET-CT findings were confirmed by clinical, radiological follow-up and biopsy in some cases.

Results:PET-CT imaging findings of a total of 37 patients with suspected tumor thrombus (25 men, 12 women, mean age: 53.62-range: 8-82) were evaluated, retrospectively. Tumor thrombus in 11 segments in 8 patients (9 linear, 2 focal) and benign thrombus in 45 regions in the other 29 patients were reported in the evaluation of a total of 56 thrombi region in 37 patients on visual analysis and according to the increased metabolic activity. The most common region of thrombosis was defined as vena cava inferior. SUVmax values ranged from 7.91 to 20 (mean: 12.8) in 8 tumor thrombus patients. Compared to mediastinal region increased metabolic activity was not detected in none of the 29 patients with benign thrombus and these patients were treated with anticoagulant agents.

Conclusion:As a conclusion, FDG PET-CT imaging may be useful in oncological patients when radiological imaging findings are suspicious for tumor thrombus.

Keywords: FDG; PET-CT; Tumor Thrombus

Abbreviations: VTE: Venous Thromboembolism; TT: Tumor Thrombosis; US: Ultra Sonography; CECT: Contrast-Enhanced Computed Tomography; MR: Magnetic Resonance Imaging; FDG: Fluoro-De-Oxyglucose; PET-CT: Positron Emission Tomography/Computed Tomography

Abstract| Introduction| Materıals and Methods| Results/a>| Discussion| Conclusion| References|